Oracle Associates LLC insider trades: Biolase (BIOL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Oracle Associates LLC reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2017 | BIOL | ↑ Buy | 12,545,615 | $0.43 | $5.4M | Indirect | Dec 6, 2017 (1d) |
| Feb 17, 2017 | VRML | ↑ Buy | 617,731 | $1.40 | $865K | Indirect | Feb 17, 2017 (0d) |
| Jul 14, 2015 | VRML | ↑ Buy | 512,043 | $1.96 | $1.0M | Indirect | Jul 16, 2015 (2d) |
| May 12, 2015 | HNSN | ↑ Buy | 18,888,681 | $0.65 | $12.3M | Indirect | May 14, 2015 (2d) |
| Dec 23, 2014 | VRML | ↑ Buy | 972,222 | $1.44 | $1.4M | Indirect | Dec 29, 2014 (6d) |
| Aug 8, 2013 | HNSN | ↑ Buy | 8,101,810 | $1.23 | $10.0M | Indirect | Aug 8, 2013 (0d) |
| Feb 12, 2008 | ACCP | ↓ Sell | 173,116 | $4.76 | $824K | Indirect | Jun 10, 2008 (119d) |
| Feb 12, 2008 | ACCP | ↑ Buy | 571,397 | $1.27 | $728K | Indirect | Jun 10, 2008 (119d) |
| Oct 26, 2006 | MEDW | ↓ Sell | 97,000 | $8.25 | $800K | Indirect | Oct 31, 2006 (5d) |
| Oct 26, 2006 | MEDW | ↓ Sell | 3,000 | $8.25 | $25K | Direct | Oct 31, 2006 (5d) |
| Aug 9, 2006 | MEDW | ↓ Sell | 66,870 | $8.00 | $535K | Indirect | Aug 11, 2006 (2d) |
| Feb 17, 2006 | MEDW | ↓ Sell | 2,997 | $12.12 | $36K | Indirect | Feb 21, 2006 (4d) |
| Sep 29, 2005 | MEDW | ↓ Sell | 16,000 | $8.00 | $128K | Indirect | Oct 3, 2005 (4d) |
| Sep 29, 2005 | MEDW | ↓ Sell | 4,000 | $8.00 | $32K | Direct | Oct 3, 2005 (4d) |
| Sep 7, 2005 | MEDW | ↓ Sell | 68,000 | $9.03 | $614K | Indirect | Sep 9, 2005 (2d) |
| Sep 7, 2005 | MEDW | ↓ Sell | 7,000 | $9.03 | $63K | Direct | Sep 9, 2005 (2d) |
| Aug 24, 2005 | MEDW | ↓ Sell | 1,000 | $9.85 | $10K | Direct | Aug 26, 2005 (2d) |
| Aug 22, 2005 | MEDW | ↓ Sell | 10,000 | $9.85 | $99K | Direct | Aug 24, 2005 (2d) |
| Aug 22, 2005 | MEDW | ↓ Sell | 5,000 | $9.85 | $49K | See | Aug 24, 2005 (2d) |
| Aug 4, 2005 | MEDW | ↓ Sell | 47,100 | $9.74 | $459K | Indirect | Aug 5, 2005 (1d) |
| Aug 4, 2005 | MEDW | ↓ Sell | 12,900 | $9.75 | $126K | Direct | Aug 5, 2005 (1d) |
| Feb 1, 2005 | ACCP | ↑ Buy | 30,200 | $2.69 | $81K | Indirect | Jun 10, 2008 (1225d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Oracle Associates LLC's insider trades
Oracle Associates LLC is a 10% owner of Biolase (BIOL). Since Feb 1, 2005, it has reported 8 open-market purchases worth $31.8M and 14 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (10 filings), conversions (7 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.